Evidence map›Paper›PMID 27693002›Full record

ReviewAtherosclerosis2016

The role of miRNAs in cardiovascular disease risk factors.

Joy N Jones Buie, Andrew J Goodwin, James A Cook, Perry V Halushka, Hongkuan Fan

Open access · greenAbstract readReview
In one paragraph

Review in Atherosclerosis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Review
  11. Analysis of miRNA Associated with Coronary Artery Calcification.Computational and mathematical methods in medicine · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Oxidative Stress-Responsive MicroRNAs in Heart Injury.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joy N Jones BuieMedical University of South Carolina, Department of Pathology and Laboratory Medicine, 173 Ashley Avenue, Suite CRI 605B, Charleston, United States. Electronic address: jonejn@musc.edu.
Andrew J GoodwinMedical University of South Carolina, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Charleston, United States.
James A CookMedical University of South Carolina, Department of Neurosciences, Charleston, United States.
Perry V HalushkaMedical University of South Carolina, Department of Pharmacology, Charleston, United States.
Hongkuan FanMedical University of South Carolina, Department of Pathology and Laboratory Medicine, 173 Ashley Avenue, Suite CRI 605B, Charleston, United States.
Medical University of South Carolina · US

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
TRAINING TO IMPROVE CARDIOVASCULAR THERAPIEST32HL007260 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MENICK, DONALD R. · 1985 to 2021
$11.1M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
The Role of Eicosanoids in ShockR01GM027673 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI COOK, JAMES A. · 1985 to 2015
$5.7M
The Beneficial Effects of Endothelial Progenitor Cells in the Vascular Dysfunction of SepsisR01GM113995 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FAN, HONGKUAN · 2015 to 2019
$1.9M
South Carolina Clinical & Translational Research Institute (SCTR)KL2TR000060 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$807k
NCATS NIH HHS KL2 TR000060NCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1 TR001450NHLBI NIH HHS T32 HL007260NIGMS NIH HHS R01 GM027673NIGMS NIH HHS R01 GM113995
6 · The paper itself

Abstract

Coronary artery disease and atherosclerosis are complex pathologies that develop over time due to genetic and environmental factors. Differential expression of miRNAs has been identified in patients with coronary artery disease and atherosclerosis, however, their association with cardiovascular disease risk factors, including hyperlipidemia, hypertension, obesity, diabetes, lack of physical activity and smoking, remains unclear. This review examines the role of miRNAs as either biomarkers or potential contributors to the pathophysiology of these aforementioned risk factors. It is intended to provide an overview of the published literature which describes alterations in miRNA levels in both human and animal studies of cardiovascular risk factors and when known, the possible mechanism by which these miRNAs may exert either beneficial or deleterious effects. The intent of this review is engage clinical, translational, and basic scientists to design future collaborative studies to further elucidate the potential role of miRNAs in cardiovascular diseases.

Indexed as

AnimalsBiomarkersCardiovascular DiseasesCell CommunicationCholesterolCoronary Artery DiseaseHomeostasisHumansHyperlipidemiasHypertensionLipoproteins, HDLLipoproteins, LDLMiceMicroRNAsNicotianaObesityBiomarkersCholesterolLipoproteins, HDLLipoproteins, LDLMicroRNAsCardiovascular diseaseCoronary artery diseasemiRNAReviewRisk factors

Identifiers

PMID27693002
PMCPMC5125538
OpenAlexW2523222374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.